Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Other neoplasm 1

Conditions

Uterine Cervical Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1

Interventions

Biopsy 4Cyclophosphamide 3Microarray Analysis 2Methylprednisolone 2Filgrastim 2Colposcopy 2Carboplatin 2toripalimab 1tipifarnib 1sargramostim 1sapanisertib 1pyroxamide 1pirfenidone 1penpulimab 1palbociclib 1liposomal doxorubicin 1iodixanol 1human papillomavirus vaccine, TA 1artemisinin 1arginine butyrate 1Zoledronic Acid 1Vincristine 1Video-Assisted Surgery 1Topotecan 1Tetradecanoylphorbol Acetate 1Taxes 1Tacrolimus 1Specimen Handling 1Sorafenib 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Cidofovir × Other neoplasm × Clear all
NCT00811408 2010-01-28

Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Unknown
24 enrolled
GynecologicOther neoplasm

Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡